| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/06/1995 | WO1995018105A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017904A2 Botulinum toxins for treating various disorders and associated pain |
| 07/06/1995 | CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition |
| 07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
| 07/05/1995 | EP0660716A1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
| 07/05/1995 | EP0660711A1 Novel use of inhibitors of phosphodiestersase iv |
| 07/05/1995 | CN1104637A Derivative of 2-aminopyrazine-5-carboxamide, preparation and pharmaceutical use of same |
| 07/04/1995 | US5430048 Spirocyclic benzopyran imidazolines |
| 07/04/1995 | US5429938 Methods and compositions for isolation and growth of kidney tubule stem cells, in vitro kidney tubulogenesis and ex vivo construction of renal tubules |
| 07/04/1995 | CA1336168C Method of preventing or treating toxemia in pregnancy using a thromboxane a_ receptor antagonist |
| 06/29/1995 | WO1995017411A1 Novel therapeutic carbohydrate blends useful for aiding premenstrual syndrome |
| 06/29/1995 | WO1995017410A1 Heterocyclic compounds |
| 06/29/1995 | WO1995017405A1 Indoline derivatives, method of preparation and their use as pharmaceuticals |
| 06/29/1995 | WO1995014085A3 A method for detection of alterations in the dna mismatch repair pathway |
| 06/29/1995 | CA2179402A1 Indoline derivatives, method of preparation and their use as pharmaceuticals |
| 06/29/1995 | CA2177851A1 Heterocyclic compounds |
| 06/28/1995 | EP0659747A1 Branched aminothiazole derivatives process for their preparation and pharmaceutical compositions containing them |
| 06/28/1995 | EP0659424A1 2-Phenyl-3-azoylbenzothiophenes for treating male infertility |
| 06/28/1995 | EP0659422A1 2-Phenyl-3-azoylbenzothiophenes for treating Turner's syndrome |
| 06/28/1995 | EP0659421A1 2-Phenyl-3-azoylbenzothiophenes for treating menstrual symptoms |
| 06/28/1995 | EP0659420A1 2-Phenyl-3-azoylbenzothiophenes for treating sexual precocity |
| 06/28/1995 | EP0659419A1 2-Phenyl-3-azoylthiophenes for inhibiting breast disorders |
| 06/28/1995 | EP0659417A2 Inhibition of dysfunctional uterine bleeding |
| 06/28/1995 | EP0659412A2 Inhibition of the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 06/28/1995 | EP0659411A2 Method for increasing libido in post-menopausal women |
| 06/28/1995 | EP0659213A1 Growth hormone antagonists |
| 06/28/1995 | EP0659182A1 Piperazine derivatives and salts thereof |
| 06/28/1995 | CN1104119A Medicinal liquor for curing kidney and urinary system disease and its preparation method |
| 06/27/1995 | US5428037 Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
| 06/27/1995 | CA1336048C Process for making flexographic plates with increased flexibility |
| 06/22/1995 | WO1995016707A1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY |
| 06/22/1995 | WO1995016672A1 Vitamin d amine and amide derivatives |
| 06/22/1995 | WO1995016663A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents |
| 06/22/1995 | WO1995016466A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 06/22/1995 | WO1995016442A1 Novel potassium channel agonist produced from trichoderma virens |
| 06/22/1995 | WO1995011048A3 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE IN VIVO OR $i(EX VIVO) |
| 06/22/1995 | WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 06/22/1995 | CA2179203A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents |
| 06/22/1995 | CA2179168A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 06/22/1995 | CA2179068A1 Novel potassium channel agonist produced from trichoderma virens |
| 06/22/1995 | CA2178218A1 Analogues of hgh-rh (1-29)nh2 having antagonistic activity |
| 06/22/1995 | CA2178090A1 Vitamin d amine and amide derivatives |
| 06/22/1995 | CA2138638A1 Branched-amino-substituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 06/22/1995 | CA2138513A1 Methods of inhibiting myeloperoxidase activity |
| 06/22/1995 | CA2138511A1 Methods of inhibiting atrophy of the skin and vagina |
| 06/22/1995 | CA2138510A1 Methods of inhibiting dysfunctional uterine bleeding |
| 06/22/1995 | CA2138507A1 Methods of inhibiting sexual precocity |
| 06/22/1995 | CA2138506A1 Methods of inhibiting male infertility |
| 06/22/1995 | CA2138505A1 Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder |
| 06/22/1995 | CA2138501A1 Methods of inhibiting breast disorders |
| 06/22/1995 | CA2138500A1 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 06/22/1995 | CA2138497A1 Method for increasing libido in post-menopausal women |
| 06/22/1995 | CA2138494A1 Methods of inhibiting turner's syndrome |
| 06/22/1995 | CA2138454A1 Methods of inhibiting imperfect tissue repair |
| 06/22/1995 | CA2138100A1 Methods of treating menstrual symptoms and compositions therefor |
| 06/21/1995 | EP0658169A1 Diamino acid derivatives as antihypertensives |
| 06/20/1995 | US5426226 Intermediates for making ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes |
| 06/20/1995 | US5426122 Methods for reducing blood pressure with dimercaptosuccinic acid (DMSA) |
| 06/20/1995 | US5426103 Certain macrocyclic lactam derivatives |
| 06/20/1995 | CA2017619C Use of naftopidil for the therapy of dysuria in cases of benign prostatic hypertrophy |
| 06/15/1995 | WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
| 06/15/1995 | WO1995015963A1 Bicyclene derivatives, their production and use |
| 06/15/1995 | WO1995015957A1 Chroman derivative |
| 06/15/1995 | WO1995015954A1 Heterocyclic biphenylylamides useful as 5ht1d antagonists |
| 06/15/1995 | WO1995015951A1 Novel imidazole derivative and process for producing the same |
| 06/15/1995 | WO1995015767A1 Long-acting injection suspensions and a process for their preparation |
| 06/15/1995 | CA2176825A1 C5a receptor antagonists having substantially no agonist activity |
| 06/14/1995 | EP0656786A1 Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| 06/08/1995 | WO1995015311A1 Tachykinin antagonists |
| 06/08/1995 | WO1995015309A1 Dp-iv-serine protease inhibitors |
| 06/08/1995 | WO1995015308A1 Crystalline, polymorphic form of (s,s,s)-n-(1-[2-carboxy-3-(n2-mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine |
| 06/08/1995 | WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin |
| 06/08/1995 | CA2178066A1 Dp-iv-serine protease inhibitors |
| 06/08/1995 | CA2177994A1 Tachykinin antagonists |
| 06/07/1995 | EP0656208A2 Use of synthetic huminates for the manufacture of a medicament for the treatment of disease of the mucosa |
| 06/07/1995 | EP0656001A1 Novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase |
| 06/06/1995 | US5422371 Contacting a cell with a fatty acid or fatty alcohol to prevent reduction of testosterone to 5a-dihydrotestosterone |
| 06/06/1995 | US5422359 α-aminoketone derivatives |
| 06/06/1995 | US5422349 Renin inhibitors |
| 06/01/1995 | WO1995014785A1 Composition for the in vivo production of therapeutic products |
| 06/01/1995 | WO1995014682A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 06/01/1995 | WO1995014673A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor |
| 06/01/1995 | CA2174415A1 Isoxazoline compounds useful as fibrinogen receptor antagonists |
| 06/01/1995 | CA2154475A1 4,5-diphenylimidazole derivatives, their preparation and their use as acyl coenzyme a: cholesterol-0-acyl-transferase (acat) inhibitor |
| 05/31/1995 | EP0655461A1 Cyclic amino acid derivatives having ACE and NEP inhibiting activity |
| 05/31/1995 | EP0655460A1 Pharmacotherapeutical use of glutathione derivatives |
| 05/31/1995 | EP0655089A1 Effects of actin filaments on fibrin clot structure and lysis |
| 05/31/1995 | EP0655063A1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 05/31/1995 | EP0655058A1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 05/31/1995 | EP0655056A1 Piperidinyl-terminated n-(dihydroxy alkyl)-ethynyl-alanine amides for treatment of hypertension |
| 05/31/1995 | EP0654994A1 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators |
| 05/31/1995 | CN1028655C NF-1616-904 oxide of pyrazine and medicine composition contained this compound |
| 05/30/1995 | US5420138 Bicyclic pyridines which are angiotensin II inhibitors |
| 05/30/1995 | US5420130 2-aminopyrazine-5-carboxamide derivatives, their preparation and their application in therapeutics |
| 05/30/1995 | US5420111 Somatomedins, fetal growth promoters |
| 05/30/1995 | US5420019 Stable bactericidal/permeability-increasing protein muteins |
| 05/30/1995 | CA2050303C Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
| 05/30/1995 | CA2016326C Pyrido-pyridazinone acetic acids for treating chronic diabetic complications |
| 05/30/1995 | CA1335733C 1h-indazole-3-acetic acids as aldose reductase inhibitors |